Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Johnathan A. Engh
A First-In-Class TWIST1 Inhibitor With Activity in Oncogene-Driven Lung Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Related publications
Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer
Oncologist
Cancer Research
Medicine
Oncology
When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
Current Treatment Options in Oncology
Oncology
Pharmacology
A Novel Imidazopyridine PI3K Inhibitor With Anticancer Activity in Non-Small Cell Lung Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Amplifying Outcomes: Checkpoint Inhibitor Combinations in First‐Line Non‐Small Cell Lung Cancer
Oncologist
Cancer Research
Medicine
Oncology
P53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer
Cancer Research
Cancer Research
Oncology
A Novel Dual PI3Kα/mTOR Inhibitor PI-103 With High Antitumor Activity in Non-Small Cell Lung Cancer Cells
International Journal of Molecular Medicine
Medicine
Genetics
Anti-Tumour Activity of a First-In-Class Agent NUC-1031 in Patients With Advanced Cancer: Results of a Phase I Study
British Journal of Cancer
Cancer Research
Oncology
Genomic Profiling Identifies TITF1 as a Lineage-Specific Oncogene Amplified in Lung Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology